Meningitis and encephalitis in children: An update

Neurologic Clinics

Volumn 20, Issue 4, 2002, Pages 1013-1038

  Bonthius, Daniel J ^a,b   Karacay, Bahri ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

BACTERIAL MENINGITIS; CHILD; ENCEPHALITIS; FEBRILE CONVULSION; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN HERPESVIRUS 6; INFLAMMATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MENINGITIS; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIAE; WEST NILE FLAVIVIRUS;

ANTI-INFLAMMATORY AGENTS; BRAIN; CHILD; ENCEPHALITIS; HERPESVIRUS 6, HUMAN; HUMANS; INTERLEUKIN-1; MAGNETIC RESONANCE IMAGING; MENINGITIS, BACTERIAL; ROSEOLOVIRUS INFECTIONS; STEROIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036828394     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(02)00016-6     Document Type: Review

References (141)

1. Coyle PK. Overview of acute and chronic meningitis. Neurol Clin North Am 1999;17:691-710.
2. McNamara JO, Whitney KD, Andrews PI, et al. Evidence for glutamate receptor autoimmunity in the pathogenesis of Rasmussen encephalitis. Adv Neurol 1999;79:543-50.
3. Quagliarello VJ, Scheld WM. Bacterial meningitis: Pathogenesis, pathophysiology, and progress. N Engl J Med 1992;327:864-72.
4. Tunkel AR, Wispelwey B, Scheld WM. Pathogenesis and pathophysiology of meningitis. Infect Dis Clin North Am 1990;4:555-81.
5. Parkkinen J, Korhonen T, Pere A, et al. Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis. J Clin Invest 1988;81:860-5.
6. Simberkoff MS, Moldover NH, Rahal J. Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluid. A regional host deficiency. J Lab Clin Med 1980;95:362-72.
7. Zwahlen A, Nydegger UE, Vaudaux P, et al. Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: Early response during bacterial meningitis. J Infect Dis 1982;145:635-46.
8. Quagliarello VJ, Wispelway B, Long WJ, et al. Recombinant human interleukin-I induces meningitis and blood brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest 1991;87:1360-6.
9. Ramilo O, Saez-Llorens X, Mertsola J, et al. Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation. J Exp Med 1990;172:497-507.
10. Bogdan I, Leib SL, Bergeron M, et al. Tumor necrosis factor-alpha contributes to apoptosis in hippocampal neurons during experimental group B streptococcal meningitis. J Infect Dis 1997;176:693-7.
11. Dawson VL, Dawson TM. Nitric oxide in neuronal degeneration. Proc Soc Exp Biol Med 1996;211:33-40.
12. Kornecki E, Ehrlich YH. Neuroregulatory and neuropathological actions of the etherphospholipid platelet-activating factor. Science 1988;240:1792-4.
13. Nathan C. Inducible nitric oxide synthase: What difference does it make? J Clin Invest 1997;100:2417-23.
14. Pfister HW, Scheld WM. Brain injury in bacterial meningitis: Therapeutic implications. Curr Opin Neurol 1997;10:254-9.
15. Dinarello CA. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 1991;163:1177-84.
16. Igarashi M, Gilmartin RC, Gerald B, et al. Cerebral arteritis and bacterial meningitis. Arch Neurol 1984;41:531-5.
17. Tureen JH, Dworkin RJ, Kennedy SL, et al. Loss of cerebrovascular autoregulation in experimental meningitis in rabbits. J Clin Invest 1990;85:577-81.
18. Feigin RD, Pearlman E. Bacterial meningitis beyond the neonatal period. In: Feigin RD, Cherry JD, editors. Textbook of Pediatric Infectious Diseases. 4th Edition. Philadelphia: WB Saunders; 1998. p. 400-29.
19. Dinarello CA, Mier JW. Lymphokines. N Engl J Med 1987;317:940-5.
20. Niemoller UM, Tauber MG. Brain edema and increased intracranial pressure in the pathophysiology of bacterial meningitis. Eur J Clin Microbiol Infect Dis 1989;8:109-17.
21. Quagliarello VJ, Long WJ, Scheld WM. Morphologic alterations of the blood brain barrier with experimental meningitis in the rat: Temporal sequence and role of encapsulation. J Clin Invest 1986;77:1084-95.
22. Scheld WM, Dacey RG, Winn HR, et al. Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone. J Clin Invest 1980;66:243-53.
23. Ashwal S, Tomasi L, Schneider S, Perkin R, Thompson J. Bacterial meningitis in children: Pathophysiology and treatment. Neurology 1992;42:739-48.
24. Cabral DA, Flodmark O, Farrell K, Speert DP. Prospective study of computed tomography in acute bacterial meningitis. J Pediatr 1987;111:201-5.
25. Goiten KJ, Tamir I. Cerebral perfusion pressure in central nervous system infections in infancy and childhood. J Pediatr 1983;103:40-3.
26. Tauber MG. Brain edema, intracranial pressure and cerebral blood flow in bacterial meningitis. Pediatr Infect Dis J 1989;8:915-7.
27. Dodge PR, Swartz MN. Bacterial meningitis: A review of selected aspects. II. Special neurologic problems, post meningitis complications and clinicopathological correlations. N Engl J Med 1965;272:954-60.
28. Gaussorgues P, Guerin C, Boyer F, et al. Intracranial hypertension in comatose bacterial meningitis. Presse Med 1987;16:1420-3.
29. Klein JO, Feigen RD, McCracken GH, Jr. Report of the task force on diagnosis and management of meningitis. Pediatrics 1986;78(Suppl):959-82.
30. Sell SH. Long term sequelae of bacterial meningitis in children. Pediatr Infect Dis J 1983;2:90-3.
31. Kadurugamuwa JL, Hengstler B, Zak O. Effects of anti-inflammatory drugs on arachidonic acid metabolites and cerebrospinal fluid proteins during infectious pneumococcal meningitis in rabbits. Pediatr Infect Dis J 1987;6:1153-4.
32. Mertsolla J, Ramilo O, Mustafa MM, et al. Release of endotoxin after antibiotic treatment of gram negative bacterial meningitis. Pediatr Infect Dis J 1989;8:904-6.
33. Syrogiannopoulos GA, Olsen K, Reisch JS, McCracken GH, Jr. Dexamethasone in the treatment of experimental Haemophilus influenzae type B meningitis. J Infect Dis 1987;155:213-9.
34. Tauber MG, Khayam-Bashi H, Sande MA. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis 1985;151:528-34.
35. Lebel MH, Hoyt J, Waagner DC, et al. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. Am J Dis Child 1989;143:301-6.
36. McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 1997;278:925-31.
37. Mustafa MM, Ramilo O, Saez-Llorens X, et al. Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients. Am J Dis Child 1990;144:883-7.
38. Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991;324:1525-31.
39. Lebel MH, Freji BJ, Syrogiannopoulous GA, et al. Dexamethasone therapy for bacterial meningitis: Results of two double-blind, placebo controlled trials. N Engl J Med 1988;319:964-71.
40. Girgis NI, Farid Z, Mikhail IA, et al. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J 1989;8:848-51.
41. Kaplan SL. Dexamethasone for children with bacterial meningitis: Should it be routine therapy? Am J Dis Child 1989;143:290-2.
42. Cabellos C, Martinez-Lacasa J, Martos A, et al. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrob Agents Chemother 1995;39:2158-60.
43. Pacheco TR, Cooper CK, Hardy DJ, et al. Failure of cefotaxime treatment in an adult with Streptococcus pneumoniae meningitis. Am J Med 1997;102:303-5.
44. Paris MM, Hickey SM, Uscher MI, et al. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1994;38:1320-4.
45. American Academy of Pediatrics Committee on Infectious Diseases. Haemophilus influenzae infections. In: Pickering LK, editor. 2000 Red Book. 25th Edition. Elk Grove Village, IL: American Academy of Pediatrics; 2000. p. 262-72.
46. American Academy of Pediatrics Committee on Infectious Diseases. Pneumococcal infections. In: Pickering LK, editor. 2000 Red Book. 25th Edition. Elk Grove Village, IL: American Academy of Pediatrics; 2000. p. 452-60.
47. Canadian Paediatric Society. Infectious Diseases and Immunization Committee: Dexamethasone therapy for bacterial meningitis: A time for caution. CMAJ 1990;142:307-8.
48. Finch RG, Mandragos C. Corticosteroids in bacterial meningitis: Not yet justified for all patients. BMJ 1991;302:607-8.
49. Grimwood K. Dexamethasone treatment for bacterial meningitis. J Paediatr Child Health 1990;26:311-3.
50. American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000;106:362-6.
51. Mustafa MM, Ramilo O, Mertsola J, et al. Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influenzae type b meningitis. J Infect Dis 1989;160:818-25.
52. Cochi SL, Broome CV, Hightower AW. Immunization of US children with Haemophilus influenzae type b polysaccharide vaccine: A cost-effectiveness model of strategy assessment. JAMA 1985;253:521-9.
53. Wenger JD, Hightower AW, Facklam RR, et al. Bacterial meningitis in the United States, 1986: Report of a multistate surveillance study. J Infect Dis 1990;162:1316-23.
54. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. N Engl J Med 1997;337:970-6.
55. Shattuck KE, Chonmaitree T. The changing spectrum of neonatal meningitis over a fifteen year period. Clin Pediatr 1992;31:130-6.
56. Smith AL, Haas J. Neonatal bacterial meningitis. In: Scheld WM, Whitley RJ, Durack DT, editors. Infections of the Central Nervous System. New York: Raven Press; 1991. p. 313-33.
57. Friedland IR, McCracken GH, Jr. Management of infections caused by antibioticresistant Streptococcus pneumoniae. N Engl J Med 1994;331:377-82.
58. Doern GV, Heilmann KP, Huynh HK, et al. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother 2001;45:1721-9.
59. Caputo GM, Appelbaum PC, Liu HH. Infections due to penicillin-resistant pneumococci. Clinical, epidemiologic and microbiologic features. Arch Intern Med 1993;153:1301-10.
60. Ferroni A, Berche P. Alterations to penicillin-binding proteins 1A, 2B and 2X amongst penicillin-resistant clinical isolates of Streptococcus pneumoniae serotype 23F from the nasopharyngeal flora of children. J Med Microbiol 2001;50:828-32.
61. Reichler MR, Allphin AA, Breiman RF, et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992;166:1346-53.
62. Gray BM, Dillon HC, Jr. Clinical and epidemiologic studies of pneumococcal infection in children. Pediatr Infect Dis J 1986;5:201-7.
63. Friedland IR, Paris M, Ehrett S, et al. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1993;37:1630-6.
64. Viladrich PF, Gudiol F, Linares J, et al. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother 1991;35:2467-72.
65. Bradley JS, Scheld WM. The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: Current antibiotic therapy in the 1990s. Clin Infect Dis 1997;24(Suppl 2): S213-21.
66. Spach DH, Jackson LA. Bacterial meningitis. Neurol Clin North Am 1999;17:711-35.
67. Butler JC, Hofmann J, Cetron MS, et al. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis 1996;174:986-93.
68. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000;19:187-95.
69. Centers for Disease Control and Prevention. Decreased availability of pneumococcal conjugate vaccine. MMWR 2001;50:783-4.
70. Armstrong C, Lillie RD. Experimental lymphocytic choriomeningitis of monkeys and mice produced by a virus encountered in studies of the 1933 St. Louis encephalitis epidemic. Public Health Rep 1934;49:1019-22.
71. Buchmeier MJ, Zajac AJ. Lymphocytic choriomeningitis virus. In: Ahmed R, Chen I, editors. Persistent Viral Infections. New York: Wiley; 1999. p. 575-605.
72. Ambrosio AM, Feuillade MR, Gamboa GS, et al. Prevalence of lymphocytic choriomeningitis virus infection in a human population of Argentina. Am J Trop Med 1994;50:381-6.
73. Childs JE, Glass GE, Korch GW, et al. Lymphocytic choriomeningitis virus infection and house mouse (Mus musculus) distribution in urban Baltimore. Am J Trop Med Hyg 1992;47:27-34.
74. Lehman-Grube F. Portraits of viruses: Arenaviruses. Intervirology 1984;22:121-45.
75. Stephensen CB, Blount SR, Lanford RE, et al. Prevalence of serum antibodies against lymphocytic choriomeningitis virus in selected populations from two U.S. cities. J Med Virol 1992;38:27-31.
76. Komrower GM, Williams BL, Stones PB. Lymphocytic choriomeningitis in the newborn. Probable transplacental infection. Lancet 1955;1:697-8.
77. Barton LL, Budd SC, Morfitt WS, et al. Congenital lymphocytic choriomeningitis virus infection in twins. Pediatr Infect Dis J 1993;12:942-6.
78. Barton LL, Mets MB. Congenital lymphocytic choriomeningitis virus infection: Decade of rediscovery. Clin Infect Dis 2001;33:370-4.
79. Enders G, Varho-Gobel M, Lohler J, et al. Congenital lymphocytic choriomeningitis virus infection: An underdiagnosed disease. Pediatr Infect Dis J 1999;18:652-5.
80. Wright R, Johnson D, Neumann M, et al. Congenital lymphocytic choriomeningitis virus syndrome: A disease that mimics congenital toxoplasmosis or cytomegalovirus infection. Pediatrics 1997;100:e9 (Electronic publication).
81. Jahrling PB, Peters CJ. Lymphocytic choriomeningitis virus: A neglected pathogen of man. Arch Pathol Lab Med 1992;116:486-8.
82. Meyer HM, Jr, Johnson RT, Crawford IP, et al. Central nervous system syndromes of "viral" etiology: A study of 713 cases. Am J Med 1960;29:334-47.
83. Chesney PJ, Katcher ML, Nelson DB, et al. CSF eosinophilia and chronic lymphocytic choriomeningitis virus meningitis. J Pediatr 1979;94:750-2.
84. Biggar R, Woodall J, Walter P, et al. Lymphocytic choriomeningitis outbreak associated with pet hamsters: Fifty seven cases from New York state. JAMA 1975;232:494-500.
85. Barton LL, Peters CJ, Ksiazek TG. Lymphocytic choriomeningitis virus: An unrecognized teratogenic pathogen. Emerg Infect Dis 1995;1:152-3.
86. Mets MB, Barton LL, Khan AS, et al. Lymphocytic choriomeningitis virus: An underdiagnosed cause of congenital chorioretinitis. Am J Ophthalmol 2000;130:209-15.
87. Brezin AP, Thulliez P, Cisneros B, et al. Lymphocytic choriomeningitis virus chorioretinitis mimicking ocular toxoplasmosis in two otherwise normal children. Am J Ophthalmol 2000;130:245-7.
88. Bonthius DJ, Mahoney J. LCM virus infection of the developing rat brain: Acute and delayed-onset pathology [abstract]. Soc Neurosci Abstr 2001;27:658.8.
89. Bonthius DJ, Mahoney J, Buchmeier M, et al. Critical role for glial cells in the propagation and spread of lymphocytic choriomeningitis virus in the developing rat brain. J Virol 2002;76:6618-36.
90. del Cerro M, Grover D, Monjan AA, et al. Congenital retinitis in the rat following maternal exposure to lymphocytic choriomeningitis virus. Exp Eye Res 1984;38:313-24.
91. Monjan AA, Gilden DH, Cole GA, et al. Cerebellar hypoplasia in neonatal rats caused by lymphocytic choriomeningitis virus. Science 1971;171:194-6.
92. Pearce BD, Steffensen SC, Paoletti AD, et al. Persistent dentate granule cell hyperexcitability after neonatal infection with lymphocytic choriomeningitis virus. J Neurosci 1996;16:220-8.
93. Bonthius DJ, Mahoney J, Van Hoesen GW, Perlman S. Cerebellar granule cell death induced by LCM virus in neonatal rats is lobule-dependent and apoptotic [abstract]. Soc Neurosci Abstr 1999;25:486.
94. Monjan AA, Bohl LS, Hudgens GA. Neurobiology of LCM virus infection in rodents. Bull World Health Org 1975;52:487-92.
95. Levison SW, Goldman JE. Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain. Neuron 1993;10:201-12.
96. Luskin MB. Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron 1993;11:173-89.
97. Monjan AA, Cole GA, Nathanson N. Pathogenesis of LCM disease in the rat. In: Lehmann-Grube F, editor. Lymphocytic Choriomeningitis Virus and Other Arena Viruses. New York: Springer-Verlag; 1973. p. 195-206.
98. Centers for Disease Control and Prevention. Outbreak of West Nile-like viral encephalitis - New York, 1999. Morb Mortal Wkly Rep 1999;48:845-9.
99. Hayes CG. West Nile fever. In: Monath TP, editor. The Arboviruses: Epidemiology and Ecology, vol. 5. Boca Raton, FL: CRC Press; 1988. p. 59-88.
100. Lanciotti RS, Roehrig JT, Deubel V, et al. Origin of the West Nile Virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999;286:2333-7.
101. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001;344:1807-14.
102. Deubel V, Gubler DJ, Layton M, Malkinson M. West Nile virus: A newly emergent epidemic disease. Emerg Infect Dis 2001;7:536.
103. Centers for Disease Control and Prevention. Update: Surveillance for West Nile virus in overwintering mosquitoes - New York, 2000. MMWR CDC Surveill Summ 2000;49:178-9.
104. Centers for Disease Control and Prevention. Serosurveys for West Nile virus infection New York and Connecticut counties. MMWR CDC Surveill Summ 2000;50:37-9.
105. Marburg K, Goldblum H, Sterk VV, et al. The natural history of West Nile fever: Clinical observations during an epidemic in Israel. Am J Hyg 1956;64:259-63.
106. Craven RB, Roehrig JT. West Nile virus. JAMA 2001;286:651-3.
107. Tyler KL. West Nile virus encephalitis in America. N Engl J Med 2001;344:1858-9.
108. Beaty BJ, Calisher CH, Shope RE. Arboviruses. In: Schmidt NJ, Emmons RW, editors. Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections. 6th Edition. Washington, DC: American Public Health Association; 1989. p. 797-855.
109. Tardei G, Ruta S, Chitu V, et al. Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile virus infection. J Clin Microbiol 2000;38:2232-9.
110. Briese T, Glass WG, Lipkin WI. Detection of West Nile virus sequences in cerebrospinal fluid. Lancet 2000;355:1614-5.
111. Fine A, Mostashari F, Nash D, Layton M. Testing for West Nile virus. Lancet 2000;356:1110-11.
112. Jordan I, Briese T, Fischer N, et al. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells. J Infect Dis 2000;182:1214-7.
113. Centers for Disease Control and Prevention. Guidelines for Arbovirus Surveillance in the United States. Fort Collins, CO: US Department of Health and Human Services, Centers for Disease Control and Prevention; 1993.
114. Mount GA, Biery TL, Haile DG. A review of ultralow-volume aerial sprays of insecticide for mosquito control. J Am Mosq Control Assoc 1996;12:601-18.
115. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986;234:596-601.
116. Yamanishi K, Okuno T, Shiraki K, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988;8594:1065-7.
117. Barone SR, Kaplan MH, Krilov LR. Human herpesvirus-6 infection in children with first febrile seizures. J Pediatr 1995;127:95-7.
118. Kondo K, Nagafuji H, Hata A, et al. Association of human herpesvirus-6 infection of the central nervous system with recurrence of febrile convulsions. J Infect Dis 1993;167:1197-200.
119. Suga S, Suzuki K, Ihira M, et al. Clinical characteristics of febrile convulsions during primary HHV-6 infection. Arch Dis Child 2000;82:62-6.
120. Luppi M, Barozzi P, Maiorana A, et al. Human herpesvirus-6 infection in normal human brain tissue. J Infect Dis 1994;169:943-4.
121. Jee SH, Long CE, Schnabel KC, et al. Risk of recurrent seizures after a primary human herpesvirus 6-induced febrile seizure. Pediatr Infect Dis J 1998;17:43-8.
122. Ablashi DV, Lusso P, Hung CL, et al. Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6). Int J Cancer 1988;42:787-91.
123. Caserta MT, Hall CB, Schnabel K, et al. Neuroinvasion and persistence of human herpes virus 6 in children. J Infect Dis 1994;170:1586-9.
124. He J, McMarthy M, Zhou Y, et al. Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 1996;70:1296-300.
125. Ueda T, Miyake Y, Imoto K, et al. Distribution of human herpesvirus 6 and varicellazoster virus in organs of a fatal case with exanthem subitum and varicella. Acta Paediatr Jpn 1996;38:590-5.
126. Hukin J, Farrell K, MacWilliams LM, et al. Case control study of primary human herpesvirus 6 infection in children with febrile seizures. Pediatrics 1998;101:e3 (Electronic publication).
127. Teach SJ, Wallace HW, Evans MJ, et al. Human herpesviruses types 6 and 7 and febrile seizures. Pediatr Neurol 1999;21:699-703.
128. Flamand L, Gosselin J, D'Addario M, et al. Human herpesvirus 6 induces interleukin-1b and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J Virol 1991;65:5105-10.
129. Jankowski JL, Patterson PH. The role of cytokines and growth factors in seizures and their sequelae. Prog Neurobiol 2001;63:125-49.
130. Kikuta H, Nakane A, Lu H, et al. Interferon induction by human herpesvirus-6 in human mononuclear cells. J Infect Dis 1990;162:35-8.
131. Bertolani MF, Portolani M, Marotti F, et al. A study of childhood febrile convulsions with particular reference to HHV-6 infection: Pathogenic considerations. Childs Nerv Syst 1996;12:534-9.
132. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994;330:1356-60.
133. Yoshikawa T, Asano Y. Central nervous system complications in human herpesvirus-6 infection. Brain Dev 2000;22:307-14.
134. Jones CM, Dunn HG, Thomas EE, et al. Acute encephalopathy and status epilepticus associated with human herpes virus 6 infection. Dev Med Child Neurol 1994;36:646-50.
135. Carrigan DR, Harrington D, Knox KK. Subacute leukoencephalitis caused by CNS infection with human herpesvirus-6 manifesting as acute multiple sclerosis. Neurology 1996;47:145-8.
136. Asano Y, Yoshikawa T, Kajita Y, et al. Fatal encephalitis/encephalopathy in human herpesvirus-6 infection. Arch Dis Child 1992;67:1484-5.
137. Hill AE, Hicks EM, Coyle PV. Human herpesvirus-6 and central nervous system complications. Dev Med Child Neurol 1994;36:651-2.
138. Oki J, Yoshida H, Tokumitsu A, et al. Serial neuroimages of acute necrotizing encephalopathy associated with human herpesvirus 6 infection. Brain Dev 1995;17:356-9.
139. Yanagihara K, Tanaka-Taya K, Itagaki Y, et al. Human herpesvirus 6 meningoencephalitis with sequelae. Pediatr Infect Dis J 1995;14:240-2.
140. American Academy of Pediatrics Committee on Infectious Diseases. Dexamethasone therapy for bacterial meningitis in infants and children. Pediatrics 1990;86:130-3.
141. Larsen PD, Wright R. Early clinical manifestations and long-term outcome in symptomatic congenital lymphocytic choriomeningitis virus infection [abstract]. Neurology 2001;56:A39-40.